Biotechnology

(Vienna—August 8, 2022—10:30 a.m. CEST) —  In the initial NADIM trial, neoadjuvant chemoimmunotherapy was shown to be highly effective in patients with resectable stage IIIA non-small cell lung cancer.  Today, the researchers from the...

Flagship Pioneering announced the launch of Apriori Bio, a health security company providing variant-proof protection against rapidly evolving viruses. Apriori has developed Octavia, a unique biology-informed AI platform that can infer the full landscape...

The Lithuanian Biotechnology Association (LBTA) said on Friday that they signed a memorandum of understanding (MOU) with Korea Biotechnology Industry (Korea BIO) to establish stronger cooperation with Korean bio-companies in the field of high...

NELSON Trial Protocol More Sensitive than NLST and May Increase the Benefits of Lung Cancer Screening, While Reducing Unnecessary Follow-up Procedures  Credit: Koen de Nijs, Erasmus University Medical Center Rotterdam, the Netherlands NELSON Trial Protocol More...

Stakeholders in Nigeria’s agricultural industry say they are interested in using biotechnology to boost agricultural production. Advertisement They claim that this is a significant solution to many of the country’s...

DNA-based information is a new interdisciplinary field linking information technology and biotechnology. The field hopes to meet the enormous need for long-term data storage by using DNA as an information storage medium. Despite DNA's...

CHICAGO, Aug. 5, 20222—It was only a matter of time—before Influit Energy would need to hire more scientists, before the 2,100-square-foot lab space that the company occupies in Chicago’s West Loop neighborhood would grow too small,...

The Alzheimer’s disease (AD) community is buzzing over a major news story recently published in Science, which raised concerns about multiple images published in a groundbreaking paper sixteen years ago that has driven support–and...

Amgen Chairman and CEO Robert A. Bradway Amgen has agreed to acquire ChemoCentryx for approximately $3.7 billion, the companies said today, in a deal that expands the buyer’s autoimmune portfolio with an approved drug and...

Link to Google Drive folder containing embargoed press release with images: Credit: U.S. National Park Service Link to Google Drive folder containing embargoed press release with images: https://drive.google.com/drive/folders/1oiotBy0I6vI-KPW5xXHPBQ0uuFYDhNsi?usp=sharing Embargoed by the Journal of Glaciology For public release at 4...